CNBCLean R·
We're raising our price target on Cardinal Health after another stellar quarter of profits
The drug distributor also raised its full-year earnings guidance.
Read at CNBC →
Business · 1 sources covering this
We're raising our price target on Cardinal Health after another stellar quarter of profits
The drug distributor also raised its full-year earnings guidance.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/0ecd5430c860b05037c6ab0998676a42f2ef0c06" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="We're raising our price target on Cardinal Health after another stellar quarter of profits"></iframe>
